In Case You Missed It, U.S. Senator Catherine Cortez Masto (D-Nev.) is sounding the alarm over the Supreme Court agreeing to take up a case that could restrict access to the abortion pill mifepristone—the first major case on women’s reproductive rights since the Court overturned Roe v. Wade last year.
The U.S. Supreme Court’s announcement Wednesday that it would hear a case that will decide abortion pill access across the U.S. did not come as a surprise to Nevada Democratic U.S. Sen. Catherine Cortez Masto.
“We’ve seen the tragic consequences of abortion restrictions across the country and it started with this court,” Cortez Masto said in an interview Thursday. “Remember, we had former president Trump and Mitch McConnell stack the United States Supreme Court with these far-right judges in the hopes that they would overturn Roe v. Wade, and that’s exactly what they’ve done.”
“We see now that it continues the erosion of the rights of women and further restricts their access to essential medicine,” she said. […]
The Supreme Court this time will decide next whether to restrict the abortion drug mifepristone. The ruling could have a big impact on women here in Nevada.
Today, Senator Catherine Cortez Masto talked about the high court’s decision to take up the case, saying justices could make it a lot harder to get access to the pill, even in states like Nevada where abortion is legal. […]
Cortez Masto: “… A lot of women are going to be hindered from having access to this medication because they’ve got to work. They don’t always have the ability to get to there or travel four hours to get there. So this is further restricting women’s access to essential health care medication for the reproductive rights.“
Next year when the U.S. Supreme Court decides whether to restrict the abortion drug mifepristone. The ruling could have an impact on Nevada.
Today Senator Catherine Cortez Masto talking to us about the justices could make it a lot harder to get access to the pill—even in states like Nevada, where abortion is legal. […]
Cortez Masto: “It means to me that a lot of women are going to be hindered from having access to this medication because they have got to work. They don’t always have the ability to travel four hours to get there.”
Mifepristone is used in more than half of the abortions in the U.S. It’s been available for more than 20 years. The Supreme Court is expected to weigh in on the case by June, during the 2024 election.
The Supreme Court is hearing a dispute over access to the abortion pill mifepristone. Senator Catherine Cortez pointed out that reducing access will be hurting states like Nevada where abortion remains legal.
Cortez Masto: “This is perfect example of a case now going to the U.S. Supreme Court again, and the court is going to weigh in on whether women can access essential medication that they need based on the advice of their doctor.”
If the supreme court agrees with the lower court… it would prohibit the drug from being ordered over the phone and sent in the mail, and would shorten the usage time from 10 weeks to seven.
Senator Catherine Cortez Masto says ever since the overturning of Roe v. Wade, the Supreme Court has been restricting and taking away women’s rights when it comes to their reproductive freedom.
Cortez Masto: “It’s outrageous. Look at what happened to Kate Cox. It is outrageous that women who already in a difficult situation are required to have to go to a Court of law.
At the end of the day it requires so many voters out there who care about this issue. I believe a majority of Americans care about a woman’s right to choose.
We need to elect representatives who believe the same thing that it is a woman’s right to choose and not take away a woman’s health care essential health care when she needs it.”
Nevada Senator Cortez Masto says reproductive rights will be a big ticket. issue for the 2024 election especially here in Nevada.
Cortez Masto: “It’s so hard in our rural communities in Northern Nevada. You have to drive sometimes for hours just to see a doctor. Let alone get the care in your community because we lack the health care professionals in some of our rural communities, so this is a further restriction on access for this medication for women. And in this day and age, it’s just outrageous!”
###